Mr. Cornell is an executive with over 25 years of experience in the medical device industry. Primary focus has been new therapy development focused on innovative treatments for lung disease. He has held numerous sales and marketing management positions at Abbott Vascular, Boston Scientific Corporation and United States Surgical Corporation. The last 15 years of Mr. Cornell’s career have been spent working in the Pulmonary space with start-up companies focused on the development and commercialization of a non-invasive treatment for emphysema. In this time, Mr. Cornell has set up a global sales channel for the commercialization of this technology, focused on developing a referral network for the treatment of the disease, assisted in the execution and completion of numerous clinical studies and hired and managed a direct sales force in 8 countries.
Mr. Keast has been with Broncus since 1998 and has been a leader and contributor to nearly all products developed at Broncus as served as Principal R&D Engineer, Senior R&D Engineer and R&D Engineer. Prior to Broncus, Mr. Keast served as a Design Engineer at Stryker Endoscopy, designing and developing laparoscopic instruments such as the StrykeFlow 2, Suction Irrigator. Mr. Keast holds a B.S. in Mechanical Engineering from California Polytechnic State University in San Luis Obispo, CA.
Mr. Carlton joined Broncus Medical/Uptake Medical with approximately 30 years of medical device experience. Mr. Carlton has served in numerous sales and sales management roles throughout his career and has a tremendous amount of experience building and managing commercial sales organizations to achieve corporate growth. Mr. Carlton has had very diverse career experience with the following companies: Boston Scientific Corporation, Abbott Vascular, Synthes Spine & Biologics and most recently with MiMedx – a biopharmaceutical company developing, manufacturing and marketing regenerative biologics. At MiMedx, Mr. Carlton served as the Senior Vice President of Global sales where he lead the organization from $700k in revenue to approximately $325M over a ten year period.
Ms. Bush has been a been working with Broncus Medical for 6 years and has held a number of executive positions for start-up medical device companies for nearly 40 years, establishing and managing regulatory affairs, quality assurance, compliance functions, and clinical trials. She prepares regulatory, quality, and clinical strategies, establishes quality systems to comply with international requirements, creates risk management documents, develops product labeling, develops clinical study documents for global submissions, and writes regulatory submissions, including IDEs, 510ks, PMA supplements, technical dossiers for global approvals. She has extensive experience with sterile devices, implants, minimally invasive devices, software-controlled, combo devices, and in vitro diagnostics. Ms. Bush has authored and co-authored 5 scientific and clinical peer-reviewed publications and has 2 issued patents. Ms. Bush is a certified Regulatory Affairs Professional (RAC). She holds a BA in Human Biology from Stanford University, and an MBA in Marketing and Operations Management from Golden Gate University.
Mr. Wibowo joined Broncus Technologies in March 2006. Prior to Broncus, Mr. Wibowo served as the President of Software at CompuMed, Inc. a healthcare informatics company providing tele-cardiology and skeletal health. Mr. Wibowo was a co-founder and served as President of Engineering at CompuRAD, Inc., a medical imaging company, from November 1991 to November 1997 and as President of Software Engineering at Lumisys Incorporated, a medical imaging company, from November 1997 to January 2000 where he was responsible for design and engineering of Lumisys’ software for its line of digitizers and CR devices. Mr. Wibowo holds a B.S. in Electrical Engineering from Oregon State University and a M.S. in Electrical Engineering from the University of Arizona.
Mr. Markle came to Broncus in 2017 after holding several senior level roles at GE Healthcare and Merit Medical Endotek over the course of his 25 years in healthcare. Mr. Markle started his career at OEC Medical Systems, which was acquired by GE Healthcare in 1999, as a 20 year old working on a shipping dock. Over the course of an 18 year career he was promoted multiple times holding a wide range of commercial roles including sales, sales operations, product management and clinical management in both a US and International capacity. During his 7 years at Merit Medical Endotek, Mr. Markle lead global marketing and clinical training and successfully re-positioned the company from a non-vascular stent company to an endoscopy company focusing on both GI and pulmonary markets. During his tenure at Merit Medical, Mr. Markle successfully directed growth from $6M in annual review to well over $35M. Mr. Markle holds a B.S. in International Relations and Business Administration from the University of Utah and an MBA from Westminster College.
Julie leads the clinical program for Broncus Medical and Uptake Medical, which includes trials conducted around the world for the treatment of emphysema, lung cancer and chronic bronchitis. Julie has over 13 years of clinical affairs experience, primarily with start-up medical device companies focused in cardiology, neurology and pulmonology. She has proven successful experience in clinical trial design, development and execution of multinational studies spanning from first-in-human through post-market, with extensive knowledge of FDA and EU regulations. Prior to joining Uptake Medical, Julie worked for Cardiac Dimensions, Integrated Diagnostics, and Northstar Neuroscience in various clinical management positions.